Kidney Week

Abstract: FR-PO657

Serum and Urine Markers of Collagen Type VI Formation (Pro-C6) and Type III Degradation (C3M) Reflect Renal Function in Type 1 Diabetes

Session Information

• Diabetic and Obesity Induced Kidney Disease - Clinical - II
  November 03, 2017 | Location: Hall H, Morial Convention Center
  Abstract Time: 10:00 AM - 10:00 AM

Category: Diabetes

• 502 Diabetes Mellitus and Obesity: Clinical

Authors

• Hansen, Tine, Steno Diabetes Center Copenhagen, Gentofte, Denmark

Tine Hansen,

• Rasmussen, Daniel Guldager Kring, Nordic Bioscience, Herlev, Denmark

Daniel Guldager Kring Rasmussen,

• Pilemann-lyberg, Sascha, Steno Diabetes Center Copenhagen, Gentofte, Denmark

Sascha Pilemann-lyberg,

• Holm Nielsen, Signe, Nordic Bioscience A/S, Herlev, Denmark

Signe Holm Nielsen,

• Karsdal, Morten Asser, Nordic Bioscience, Herlev, Denmark

Morten Asser Karsdal,

• Persson, Frederik, Steno Diabetes Center Copenhagen, Gentofte, Denmark

Frederik Persson,

• Theilade, Simone, Steno Diabetes Center Copenhagen, Hellerup, Denmark

Simone Theilade,

• Genovese, Federica, Nordic Bioscience, Herlev, Denmark

Federica Genovese,

• Rossing, Peter, Steno Diabetes Center Copenhagen, Gentofte, Denmark

Peter Rossing,

Background

Progression of diabetic kidney disease is associated with renal fibrogenesis and associated with increased extracellular matrix remodeling and release of collagen fragments in urine in progressive renal disease. We evaluated associations between kidney function and a marker of collagen type VI formation (Pro-C6) and a marker of collagen type III degradation (C3M) in type 1 diabetes.

Methods

Serum and urinary levels of Pro-C6 and C3M were measured with ELISA in 668 patients with type 1 diabetes. Kidney function was evaluated as eGFR (CKD-EPI) and urinary albumin excretion rate (UAER). We applied unadjusted and adjusted linear regression analyses.Adjustment included age, sex, LDL cholesterol, smoking, HbA_1c, systolic blood pressure, UAER (in analyses of eGFR) and eGFR (in analyses of UAER). To adjust for urine output levels, the urinary markers were normalized for urinary creatinine.

Results

Of the 668 patients, 368 (55%) were male, mean±SD age was 54.6±12.6 years and eGFR 81.6±25.5 ml/min/1.73m². Median (IQR) UAER was 17 (8-65) mg/g. Both higher serum and urinary levels of Pro-C6 were associated with lower eGFR (unadjusted: p<0.001; adjusted: p<0.001) and higher UAER (unadjusted: p<0.001; adjusted: p<0.001). Lower urinary levels of C3M were associated with lower eGFR (unadjusted: p<0.001; adjusted: p<0.001) and higher UAER in the unadjusted model (p<0.001), but significance was lost after adjustment (p=0.43). Higher serum levels of C3M were associated with lower eGFR (unadjusted: p<0.001; adjusted: p=0.001) and higher UAER (unadjusted: p<0.001; adjusted: p=0.007).

Conclusion

In type 1 diabetes, higher serum and urine levels of the collagen type VI formation marker Pro-C6 were associated with poorer kidney function. Moreover, higher serum levels and lower urine levels of the collagen type III degradation marker C3M were related to poorer kidney function. Longitudinal data are needed to clarify the predictive role of these markers.

Funding

• Commercial Support – Nordic Bioscience A/S, Herlev, Denmark